These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12126895)

  • 1. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.
    Kojima Y; Xin KQ; Ooki T; Hamajima K; Oikawa T; Shinoda K; Ozaki T; Hoshino Y; Jounai N; Nakazawa M; Klinman D; Okuda K
    Vaccine; 2002 Jul; 20(23-24):2857-65. PubMed ID: 12126895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
    Askew D; Chu RS; Krieg AM; Harding CV
    J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
    Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
    J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
    Horner AA; Datta SK; Takabayashi K; Belyakov IM; Hayashi T; Cinman N; Nguyen MD; Van Uden JH; Berzofsky JA; Richman DD; Raz E
    J Immunol; 2001 Aug; 167(3):1584-91. PubMed ID: 11466380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.
    Sparwasser T; Koch ES; Vabulas RM; Heeg K; Lipford GB; Ellwart JW; Wagner H
    Eur J Immunol; 1998 Jun; 28(6):2045-54. PubMed ID: 9645386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
    J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
    Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
    J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of HIV-1 subtype C vaccine constructs induced immune response in mice by CpG motif 1826-ODN.
    Aggarwal P; Pandey RM; Seth P
    Viral Immunol; 2005; 18(1):213-23. PubMed ID: 15802966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG DNA is an effective oral adjuvant to protein antigens in mice.
    McCluskie MJ; Weeratna RD; Krieg AM; Davis HL
    Vaccine; 2000 Nov; 19(7-8):950-7. PubMed ID: 11115721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.
    Vinner L; Nielsen HV; Bryder K; Corbet S; Nielsen C; Fomsgaard A
    Vaccine; 1999 Apr; 17(17):2166-75. PubMed ID: 10367950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
    Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K
    Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.
    Barnett SW; Rajasekar S; Legg H; Doe B; Fuller DH; Haynes JR; Walker CM; Steimer KS
    Vaccine; 1997 Jun; 15(8):869-73. PubMed ID: 9234536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
    J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.
    Cho HJ; Hayashi T; Datta SK; Takabayashi K; Van Uden JH; Horner A; Corr M; Raz E
    J Immunol; 2002 May; 168(10):4907-13. PubMed ID: 11994440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
    Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
    J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
    Davila E; Celis E
    J Immunol; 2000 Jul; 165(1):539-47. PubMed ID: 10861094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG motifs for optimization of DNA vaccines.
    Davis HL
    Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors.
    Coban C; Ishii KJ; Gursel M; Klinman DM; Kumar N
    J Leukoc Biol; 2005 Sep; 78(3):647-55. PubMed ID: 15961575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.